This sounds like some very interesting work. Their release describes the DNA technology they use like this. “Botanical DNA technology is a leading brand protection and anti- counterfeiting solution since it is based on authentication of the encoded DNA in a product through forensic analysis. Applied DNA Sciences technology protects products and brands, deters counterfeit and grey market activity and safeguards corporate investment and market share. Microscopic covert DNA markers can be integrated into products and packaging, in inks, paper, coatings, adhesives, thread, textiles, polymers, liquids, holograms and microchips.” Although I wanted to become a forest ranger once the science was too much for me. I can only imagine what it takes to become a botanical DNA technologist!
Applied DNA Sciences Closes on DNA IP From Biowell
LOS ANGELES, June 20 /PRNewswire-FirstCall/ — Applied DNA Sciences, Inc. (BULLETIN BOARD: APDN) , a security solutions company whose DNA technology detects and deters counterfeiting, fraud, product diversion, and protects the corporate supply chain, today announced that on June 14th, 2005 at a General Meeting of the Shareholders of Biowell Technologies Inc., the Shareholders unanimously voted to accept the terms and conditions of the sale of the Intellectual Property to Applied DNA Sciences. This vote consummates several months of negotiations and provides global control of the technology to APDN.
APDN will establish a laboratory in the US to produce the DNA security products. The ability to produce the products in the US and to provide them as a US-owned technology opens the door for APDN to conduct business with US Federal Agencies, a primary business focus for the company.
Biowell now becomes an exclusive Licensee for Asia and certain other territories, thereby generating a royalty stream for APDN. The IP has been verified by independent laboratories and leading molecular biologists and patent attorneys.
Peter Brocklesby, president of APDN stated, “We have completed a major milestone in the reorganization of our company and the transfer of control of the technology to the US. Our efforts can now be fully focused on executing our business plan to commercialize the DNA technology for the burgeoning global security market.”
For more information contact Adrian Butash.